Tepezza (teprotumumab) is an intravenous medication marketed by Horizon Therapeutics for thyroid eye disease (TED). Patients across the country have reported permanent hearing loss, tinnitus, and related auditory injuries after receiving Tepezza infusions — risks that were not adequately disclosed when the drug came to market in January 2020. Baker Legal Team is actively representing plaintiffs in the federal Tepezza MDL and reviewing new cases nationwide.
Call Baker Legal Team at 888-468-4608 for a free, confidential consultation.
In June 2023, the Judicial Panel on Multidistrict Litigation consolidated all federal Tepezza lawsuits into MDL 3079 in the U.S. District Court for the Northern District of Illinois, before Judge Thomas M. Durkin. The consolidation was designed to streamline pretrial discovery, prevent duplicative proceedings, and avoid inconsistent judgments across federal districts. The docket has grown substantially since the initial consolidation order, and new cases continue to be filed.
Baker Legal Team is actively involved in the Tepezza MDL with cases pending on behalf of injured patients. We co-counsel on cases nationwide and accept Tepezza referrals from attorneys outside Florida.
FAQ